This study analysed the impact of transapical (TA) vs. transfemoral (TF) access site transcatheter aortic valve implantation (TAVI) on post-procedural regional left ventricular (LV) function using cardiac magnetic resonance (CMR) feature tracking (FT).
Introduction
Transcatheter aortic valve implantation (TAVI) has become an accepted treatment for high-risk or inoperable patients with symptomatic aortic stenosis. 1 -4 Two different access pathways for placing the aortic valve bioprostheses remain the preferred routes in the vast majority of patients: the transfemoral (TF) and the transapical (TA) approaches. 4, 5 Both TF and TA access TAVI have been performed on high numbers of patients. They are applied depending on individual risk profiles. While the TF access may not be applicable in patients with significant peripheral artery disease, it is the preferred approach in patients with pre-existing lung disease. During the TF procedure, there is no critical contact with the myocardium of the left ventricle. In contrast, the TA approach results in a circumscribed apical insult. There is only limited information on the impact of the different access sites on subsequent left ventricular (LV) function. Two-dimensional echocardiography is the commonly applied imaging modality for follow-up after TAVI. However, echocardiography is limited in the full analysis of LV volumes and function, in particular, related to the apical segments. 6, 7 Limitations in the analysis of the apex are caused by commonly occurring foreshortening of the LV. Thus, there has been a lack of an imaging modality allowing quantification of regional function after TAVI. Cardiac magnetic resonance (CMR) has no constraints in the functional analysis of apical segments. 8, 9 CMR feature tracking (FT) analysis of standard cine CMR images allows the quantification of systolic function of small LV regions by providing longitudinal, circumferential, and radial strain data. 10, 11 CMR-FT analysis allowed the detection of impaired segmental LV function in cases with normal visual wall motion analysis by echocardiography. 12, 13 Furthermore, global longitudinal strain was found to be a strong independent predictor of mortality in patients with aortic stenosis, superior to LV ejection fraction (EF) or visual wall motion assessment. 14 -16 This study analysed the impact of TA-TAVI vs. TF-TAVI on postprocedural regional LV function using CMR-FT.
Methods
Study design and patient population Figure 1 illustrates the number of patients approached, patients withdrawn, and also patients finally included into the study. Between January 2011 and July 2012, 96 patients underwent TAVI for severe symptomatic calcified native aortic valve stenosis at this hospital. Patients included in this study had to have normal LV EF prior to the TAVI procedure as defined by echocardiography and no history of myocardial infarction, had to be in sinus rhythm without significant ventricular ectopy, and had to have no significant regurgitation of the mitral valve (Sellers ≥2). Furthermore, patients with pacemaker therapy for conduction defects were excluded. Finally, 44 consecutive patients (22 males, mean age 82.5 + 6.3 years) fulfilling these criteria in whom a TAVI procedure was performed from either the TA or the TF access site were included in the study and underwent CMR at 3-month follow-up ( Figure 1 ). In the last 10 patients (5 patients in the TA-TAVI group and 5 patients in the TF-TAVI group), CMR was performed before the TAVI procedure and at 3-month follow-up to allow serial analysis of LV function.
Patients were referred for TAVI after a senior cardiologist and senior cardiac surgeon reached consensus that surgical replacement would be associated with either high or prohibitive risks. The inclusion and exclusion criteria of patients for implantation of the catheter-based revalving systems have been described elsewhere. 2, 3 In patients with significant femoral or iliac artery disease, TA-TAVI was the preferred procedure while TF-TAVI was preferred in the very old patients. Patients had to have a valve area of ,1 cm 2 , and aortic valve annulus diameter measuring ≥18 and ≤27 mm. The presence of a bicuspid aortic valve as defined by transoesophageal echocardiography was an exclusion criteria for TAVI. This study was approved by the ethical committee of the University Aachen and all patients gave written informed consent.
Description of the procedure and device
Twenty-four patients (55%) underwent TF-TAVI using the CoreValve Revalving TM system and 20 (45%) underwent TA-TAVI using the Edwards SAPIEN XT TM valve. Details of the devices and the technical aspects of the procedure have been previously published.
1 -3 For the TF approach, an 18-F sheet was inserted in the right or left femoral artery and the valve prosthesis was delivered retrograde over a stiff wire placed in the LV. The applied CoreValve Revalving TM system (Medtronic, Inc., Minneapolis, MN, USA) for patients treated from the TF approach consists of a self-expanding nitinol trilevel frame to which is secured a tri-leaflet bioprosthetic porcine pericardial tissue valve. In this study, prosthesis sizes of 26 and 29 mm have been used. For the TA approach, a left anterolateral mini-thoracotomy was performed. After incision of the pericardium, the LV apex was exposed and an appropriate site for the apical puncture was identified. Two pledgets supported purse string sutures with a central area of 1.5-2 cm diameter were placed into the myocardium at this apical area. These sutures were placed deep in myocardium, taking nearly full thickness of ventricular wall, and were used for closure of the apical puncture site after withdrawal of the TAVI insertion sheet. After puncture of the LV apex in the middle of the two purse string suture lines, a 22-F sheath was delivered through the myocardium into the left ventricle. The applied Edwards SAPIEN XT TM valve (Edwards Lifesciences, Irvine, CA, USA) is a balloon expandable, bovine pericardium prosthesis. In this study, prosthesis sizes of 23 and 26 mm have been used. Selection of the device size was based on measurements of the aortic root anatomy and aortic valve measurements, in particular the aortic valve annulus diameter, obtained by transoesophageal echocardiography and multislice computed tomography. Selection of prosthesis size intended slight oversizing of the prosthesis diameter related to the annulus diameter to securely fix the prosthesis within the native valve and annulus and to minimize the potential for paravalvular leaks between the prosthetic valve and native annulus. Implantation of the CoreValve prosthesis as well as the Edwards SAPIEN XT TM valve was performed as described before. 1, 2, 5 After the procedure, serum creatine kinase (CK) and CK-MB levels were determined at 8 h intervals for 24 h to define the peak.
Cardiac magnetic resonance
The CMR study was performed on a 1.5-T MR scanner (Philips Achieva, Philips Healthcare, Best, The Netherlands) with the patient in supine position, taking into account the conditions under which the CoreValve and Edwards SAPIEN XT protheses can be scanned safely. 17 A five-element cardiac synergy coil was used for signal reception and cardiac synchronization was performed with a vector-ECG. To assess LV function, standard steady-state free precession (SSFP) cine imaging (spatial resolution 1.4 × 1.4 × 8 mm; 35 phases per cardiac cycle, typical temporal resolution 24 ms; repetition time (TR): 3.1 ms, echo time (TE): 1.6 ms, flip angle 558) was performed in short repetitive end-expiratory breath hold. Cine scans were acquired in three standard long-axis geometries (two-, four-, and three-chamber views) and in short-axis orientation with full ventricular coverage without gap. LV volumes and EF were assessed from the short-axis stack according to the disk summation method (Simpson's rule) on a dedicated MR workstation (Extended Workspace, Philips Healthcare).
CMR feature tracking
SSFP sequences of the three long-axis views were analysed on a dedicated offline workstation to define segmental myocardial function (Cardiac Performance Analysis MR Figure 1 : Consort diagram illustrating number of patients approached, patients withdrawn, and also patients finally included into the study.
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lines perpendicular and parallel to the endocardial and epicardial contours are determined. Considering the myocardial wall thickening and shortening during systole, the programme calculates radial and endocardial longitudinal strain for each of the 49 segments in one view. The highest positive radial value in systole is defined as peak systolic radial strain (PSRS) and the highest negative longitudinal value in systole is defined as peak systolic longitudinal strain (PSLS). A total of 3 × 49 ¼ 147 segments of the total LV were evaluated considering the three acquired long-axis views. In addition to the detailed analysis with 49 segments in each view, the 17 segment LV model was applied for the analysis of PSLS and PSRS data. 18 For this purpose, the Segments 
Observer variability
Inter-and intra-observer variability were assessed by the analysis of 12 patients. In six consecutive patients, the CoreValve Revalving system was used and in six consecutive patients the Edwards SAPIEN XT valve was implanted. For each imaging modality, two observers independently measured PSLS and PSRS to assess inter-observer variability. These same studies were also re-examined by one observer at least 4 weeks apart to determine intra-observer variability. Intra-and inter-observer variability on global PSLS and global PSRS measurements were determined by the analysis of the deviation between re-measurements divided by the mean of both measurements.
Statistical analysis
Statistical analysis was performed with the use of the SPSS software version 21.0. Categorical data were presented as frequencies and compared with the Pearson x 2 test. Continuous data were presented as mean + SD and compared with the Student's t-test. The Pearson correlation coefficient (r) was determined to evaluate association between CK-MB after TAVI and PSRS. Inter-and intra-observer variability on global PSLS and global PSRS measurements were determined by the analysis of the deviation between re-measurements divided by the mean of both measurements. A P-value ,0.05 was considered statistically significant.
Results
Baseline characteristics of patients treated by TA and by TF-TAVI are summarized in Table 1 . TA-TAVI patients were significantly more of male gender (P ¼ 0.006). Otherwise, there were no significant differences between the two patient groups. In particular, there were no differences in the frequency of coronary artery disease and baseline LV function. Periprocedural enzyme release and global LV function data at 3 months after TAVI for the TA and the TF access groups are presented in Table 1 .
Regional LV function-radial and longitudinal strain
The analysis of peak systolic radial and longitudinal strain using FT was possible in all LV segments. There were no differences in PSRS Left ventricular function after TAVI between TA and TF-TAVI patients in the basal and mid-ventricular LV level. In contrast, considering the apical cap as well as the apical third of the LV PSRS was significantly lower in TA-TAVI patients compared with TF-TAVI patients ( Table 2) . Comparison of all non-apical segments vs. the combined apical segments and apical cap demonstrated no significant difference in the TF group (PSRS: 34.6 + 9.0 vs. 35.9 + 15.7%, respectively, P ¼ 0.702), whereas in the TA-TAVI group PSRS of the apical segments was significantly reduced compared with the non-apical segments (PSRS: 15.7 + 6.4 vs. 33.5 + 7.0%, respectively, P , 0.001). Figure 2 demonstrates end-systolic CMR images of the two-, four-, and three-chamber views of a patient with TF-TAVI (left columns) and of a patient with TA-TAVI (right columns). It demonstrates thinning of the apical myocardium and a lack of apical systolic inward motion in the TA-TAVI patient, while no regional LV dysfunction in the TF-TAVI patient is present. Combining segments of the apical cap and the apical level of the LV, representing 28% of the left ventricle, there was a reduction in PSRS of 58% in the TA-TAVI group compared with the TF-TAVI group. Figures 3 and 4 illustrate the reduction in regional LV function as defined by PSRS in the TA-compared with the TF-TAVI group. There were on average 30/147 segments (20.4% of all LV segments) in the TA-TAVI group in which PSRS was reduced by more than 50%, and on average 13/147 segments (8.8% of all LV segments) in which the PSRS was reduced by 25-50% compared with the corresponding TF-TAVI group. The global PSRS was significantly lower in the TA-TAVI group compared with the TF-TAVI group ( Table 2) . Peak CK-MB after the TAVI procedure and mean PSRS correlated weakly (r ¼ 20.31; P ¼ 0.001). The analysis of peak systolic longitudinal strain demonstrated very similar findings ( Table 2 ). There were no differences in PSLS between TA-and TF-TAVI patients in the basal and mid-ventricular LV level. In contrast, PSLS of the apical cap and the apical segments was significantly lower in the TA-TAVI group compared with the TF-TAVI group. PSLS was almost homogenous in the TF-TAVI group. In the TA-TAVI group, there was a significant reduction of PSLS in the combined apical segments and the apical cap compared with the combined basal and mid-ventricular segments (PSLS: 28.9 + 5.3 vs. 215.5 + 3.5%, respectively, P , 0.001).
Myocardial strain before vs. after TAVI
In subgroups of the TA-TAVI and TF-TAVI patients, CMR was performed before TAVI and at follow-up to determine radial and longitudinal strain data before and after TAVI (Figure 2) . Table 3 displays the strain data before and after TAVI for the TA and the TF access groups. While radial and longitudinal strain remained stable after TAVI in the TF access group, there was significant impairment in radial and longitudinal strain after the procedure in the TA-TAVI group.
Observer variability
Intra-and inter-observer variability for global PSLS and global PSRS were determined. For global PSRS, the mean intra-observer variability was 9.7 + 4.0% and the mean inter-observer variability was 16.5 + 7.9%. For global PSLS, the mean intra-observer variability was 23.1 + 9.9% and the mean inter-observer variability was 27.5 + 11.4%.
Discussion
The major findings of this study are: (i) an apical function deficit after TA-TAVI can be demonstrated using FT for the analysis of CMR cine loops, (ii) no regional function abnormality can be demonstrated after TF-TAVI using CMR-FT analysis, and (iii) the regional function abnormality after TA-TAVI exceeds a confined apical area.
Impact of TAVI access site
Patients treated by TA-TAVI have frequently been found to be sicker than those treated by the transfemoral approach. This relates, in particular, to concomitant peripheral vascular and cerebrovascular diseases. 19 Considering the different baseline characteristics, previous non-randomized studies have indicated that TA-TAVI is non-inferior to TF-TAVI with regard to early and late mortality as well as morbidity. 5 However, recent studies have indicated that TA-TAVI may be associated with local myocardial complications, impaired quality-of-life, and impaired cost-effectiveness when compared with TF-TAVI. 20 -22 After TA-TAVI higher levels of myocardial enzyme leakage have been reported compared with TF-TAVI, with CK-MB levels above the upper normal values in 95% of TA-TAVI patients and CK-MB levels more than three times the upper normal values in 33% of patients. Rodés-Cabau et al. 21 reported also that those patients with significant enzyme release had less improvement in LV EF after TAVI compared with those without enzyme release. Higher myocardial enzyme levels after cardiac surgery have been associated with impaired patient prognosis. 23, 24 Echocardiography has an important role in the preparation and periprocedural monitoring of TAVI. 25 Most recent follow-up studies on the analysis of valvular as well as LV function after TAVI have been confined to echocardiography. In contrast to our findings, which showed apical strain impairment in all patients after TA-TAVI, a recently published echocardiographic study of apical LV function The images show normal wall thickness and apical systolic inward motion in the TF-TAVI patient before and after TAVI. The TA-TAVI patient shows normal wall thickness and normal apical systolic inward motion before TAVI and reduced systolic inward motion after TA-TAVI.
Left ventricular function after TAVI before and after TA-TAVI found transient apical wall motion abnormalities in only 28% of the patients. 26 In half of them, recovery was found over time. However, transthoracic echocardiography has difficulties in the near-field display of the LV apex. Significant limitations in the display of apical structure, function, and thrombus using transthoracic echocardiography due to a failure to display the true apex have been reported. 27 Echocardiography is known to underestimate LV volumes mainly due to difficulties in LV foreshortening with a lack of LV apex display. 6, 7 This problem persists, although reduced, even with 3D echocardiography. 28 Previous analysis showing no differences in LV EF after TA vs. TF-TAVI may relate to the difficulties of 2D echocardiography to show the true apex. Furthermore, if LV EF is evaluated only at one time point after TAVI has been performed, this may not be sensitive enough to detect the impact of new regional function abnormalities on EF. Serial analysis of LV EF may be required for this purpose. However, even by serial analysis of LV EF before and after TAVI, the effect of a significant new regional function abnormality on LV EF may not be detected. A general improvement in LV EF after removal of aortic stenosis using TAVI has been reported and may counteract the new impairment of apical function. 29 This study demonstrated myocardial function impairment in the apical area 3 months after TA-TAVI using CMR-FT for regional function analysis.
The functional impairment exceeds the confined area of the apical puncture site, enclosing also the apical LV segments, while a recent study of visual wall motion assessment after TA-TAVI found only a very circumscribed akinesia confined to the LV apex. 30 This difference should be contributed to the quantitative analysis of LV function provided by CMR-FT, which allows a more subtle evaluation of changes in LV function over mere visual wall motion assessment. The study also demonstrated an association between increased enzyme release and impairment in apical LV function. Furthermore, in a subgroup of patients, serial CMR studies were performed before and after TA-or TF-TAVI. In this analysis, completely stable radial as well as longitudinal function could be confirmed in the TF-TAVI patients, while impairment of the apical radial as well as longitudinal LV function was demonstrated in the TA-TAVI patients. There are several potential mechanisms for the new regional function impairment after TA-TAVI. In the immediate myocardial area, where the large 22-F apical sheet has been induced, myocardial infarction may occur. The purse string sutures entering deep into the myocardium with a diameter of 2 cm may result in fixation and the impossibility to develop normal regional function. Even adjacent areas outside of the purse string sutures may be affected by tethered fixation. 
Feature tracking CMR
CMR has the advantage to allow unrestricted analysis of the whole LV including the apex and thereby assessment of the size and degree of any functional impairment affecting the LV apex. CMR-FT is a new modality that allows quantification of regional LV function by fast semi-automatic analysis of standard cine CMR images providing radial, circumferential, and longitudinal strain data. Thus, it allows a quantitative analysis of regional function in contrast to a mere subjective visual analysis of wall motion. It is relatively simple in usage, as it does not need additional imaging sequences such as tagging, harmonic phase magnetic resonance imaging (HARP), or displacement encoding with stimulated echoes CMR (DENSE). It therefore does not prolong examination time. It is equivalent to speckle tracking echocardiography, which has been proved to be accurate in the analysis of regional LV function and to have a prognostic value beyond those of LV EF. 31 CMR-FT has shown to detect subtle impairment of LV function not visible on standard echocardiographic examinations. 12, 13 It has been validated against HARP in the assessment of peak global circumferential strain in a population of patients with Duchenne muscular dystrophy. 10 A good correlation between the two techniques has been found.
Limitations
There are some limitations to this study. The pre-procedural echocardiographic study, which was required to show normal LV function for inclusion of the patient, may have missed small apical function defects. However, we excluded patients with a history of myocardial infarction from this study. Still, there might have been apical wall motion defects in the TA-TAVI group already before TAVI. Serial CMR studies before TAVI and at follow-up were performed only in a small number of patients. In the small subgroups, strain values tended to be lower already before TAVI in the TA group compared with the TF group. However, this subgroup analysis confirmed the significant impairment in apical function after TA-TAVI while no change has been detected in the TF-TAVI group. enhancement CMR was performed in this study to allow definition of an apical LV scar size, as this study was merely confined to the analysis of LV function. Delayed enhancement imaging primarily allows for the assessment of myocardial structure, while CMR-FT provides a quantitative analysis of function. The reproducibility of CMR-FT has been tested and a higher observer and inter-study variability for long-axis-derived strain parameters compared with short-axisderived radial and circumferential strain has been found. 11, 32 However, although this may limit the use of parameters derived from long-axis CMR-FT for individual patient assessment, no systematic faults, which would limit the use of FT on a group-based analysis, were found in those studies. Through plane motion of myocardial structures, especially on images in long-axis orientation with suboptimal depiction of the apex, may be an explanation for those findings. We therefore placed special attention on the planning of the longaxis geometries, corrected and repeated scans if inadequate apical coverage was present. FT analysis of short-axis images was not included in this study, as it does not allow the assessment of the LV apex. This study did not aim at defining the impact of a new regional wall motion abnormality after TA-TAVI on global LV function, potential LV remodelling, or patient outcome.
Conclusion
There are significant differences in regional LV function after TA-TAVI vs. TF-TAVI as demonstrated by CMR-FT. While there are no regional wall motion abnormalities after TF-TAVI, regional LV function abnormalities can be detected after TA-TAVI affecting the apical cap and apical level.
